Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel

Circulation Research

Volumn 101, Issue 2, 2007, Pages 176-184

  Blondeau, Nicolas ^a   Pétrault, Olivier ^a   Manta, Stella ^a   Giordanengo, Valérie ^a   Gounon, Pierre ^b   Bordet, Régis ^c   Lazdunski, Michel ^a   Heurteaux, Catherine ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c UNIV LILLE   (France)

Author keywords

CBF; Cerebral ischemia; Two pore domains channel TREK 1; Vasodilatation; linolenic acid

Indexed keywords

DOCOSAHEXANOIC ACID; LINOLENIC ACID; PALMITIC ACID; POLYUNSATURATED FATTY ACID; POTASSIUM CHANNEL; POTASSIUM CHANNEL TREK 1; SATURATED FATTY ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN CIRCULATION; BRAIN ISCHEMIA; CAROTID ARTERY; COLLATERAL CIRCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; LASER DOPPLER FLOWMETRY; MOUSE; MOUSE STRAIN; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; VASODILATATION;

EID: 34547561344     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.107.154443     Document Type: Article

References (30)

1. Dirnagl U, Iadecola C, Moskowitz M. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391-397.
2. Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J. 2000;19:1784-1793.
3. Blondeau N, Widmann C, Lazdunski M, Heurteaux C. Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience. 2002;109:231-241.
4. Heurteaux C, Laigle C, Blondeau N, Jarretou G, Lazdunski M. Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience. 2006;137:241-251.
5. Heurteaux C, Guy N, Laigle C, Blondeau N, Duprat F, Mazzuca M, Lang-Lazdunski L, Widmann C, Zanzouri M, Romey G, Lazdunski M. TREK-1, a K(+-) channel involved in neuroprotection and general anesthesia. EMBO J. 2004;23:2684-2695.
6. +- channel stimulated by arachidonic acid and polyunsaturated fatty acid. EMBO J. 1998;17:3297-3308.
7. Lesage F, Lazdunski M. Molecular and functional properties of two pore domain potassium channels. Am J Physiol. 2000;279:793-801.
8. +- channels. Trends Neurosci. 2001;24:339-346.
9. Gardener MJ, Johnson IT, Burnham MP, Edwards G, Heagerty AM, Weston AH. Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. Br J Pharmacol. 2004;142:192-202.
10. Bryan RM, Jr., You J, Phillips SC, Andresen JJ, Lloyd EE, Rogers PA, Dryer SE, Marrelli SP. Evidence for two-pore domain potassium channels in rat cerebral arteries. Am J Physiol Heart Circ Physiol. 2006;291:H770-H780.
11. Garry A, Fromy B, Blondeau N, Henrion D, Brau F, Gounon P, Guy N, Heurteaux C, Lazdunski M, Saumet JL. Altered acetylcholine, bradykinin and cutaneous pressure-induced vasodilation in mice lacking the TREK1 potassium channel: the endothelial link. EMBO Rep. 2007;8:354-359.
12. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19-26.
13. Petrault O, Ouk T, Gautier S, Laprais M, Gele P, Bastide M, Bordet R. Pharmacological neutropenia prevents endothelial dysfunction but not smooth muscle functions impairment induced by middle cerebral artery occlusion. Br J Pharmacol. 2005;144:1051-1058.
14. Bai N, Moien-Afshari F, Washio H, Min A, Laher I. Pharmacology of the mouse-isolated cerebral artery. Vascul Pharmacol. 2004;41:97-106.
15. Lesage F, Lazdunski M. Potassium channels with two P-domains. In: Kurachi Y, Jan LY, Lazdunski M, eds. Potassium Ion Channels. Molecular Structure, Function, and Diseases - Current Topics in Membranes. Vol 46. San Diego, CA: Academic Press;1999:199-222.
16. Patel A, Lazdunski M, Honore E. Lipid and mechano-gated 2P domain K(+-) channels. Curr Opin Cell Biol. 2001;13:422-428.
17. Reif DW, McCreedy SA. N-nitro-L-arginine and N-monomethyl-Larginine exhibit a different pattern of inactivation toward the three nitric oxide synthases. Arch Biochem Biophys. 1995;320:170-176.
18. Campbell WB, Harder DR. Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone. Circ Res. 1999;84:484-488.
19. Young WL, Barkai AI, Prohovnik I, Nelson H, Durkin M. Effect of PaCO2 on cerebral blood flow distribution during halothane compared with isoflurane anaesthesia in the rat. Br J Anaesth. 1991;67:440-446.
20. +-) channel. EMBO J. 2000;19:2483-2491.
21. Ilan N, Madri JA. PECAM-1: old friend, new partners. Curr Opin Cell Biol. 2003;15:515-524.
22. Lacombe P, Oligo C, Domenga V, Tournier-Lasserve E, Joutel A. Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy. Stroke. 2005;36:1053-1058.
23. Maingret F, Patel AJ, Lesage F, Lazdunski M, Honore E. Lysophospho-lipids open the two-pore domain mechano-gated K(+-) channels TREK-1 and TRAAK. J Biol Chem. 2000;275:10128-10133.
24. Gurney A, Osipenko O, MacMillan D, McFarlane K, Tate R, Kempsill F. Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle. Circ Res. 2003;93:957-964.
25. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci. 2002;23:374-380.
26. Seal J, Gewertz B. Vascular dysfunction in ischemia-reperfusion injury. Ann Vasc Surg. 2005;19:572-584.
27. Aliev G, Obrenovich M, Seyidova D, de la Torre J. Exploring ischemia-induced vascular lesions and potential pharmacological. Histol Histopathol. 20:261-273, 2005.
28. Windmuller O, Lindauer U, Foddis M, Einhaupl K, Dirnagl U, Heinemann U, Dreier J. Ion changes in spreading ischaemia induce rat middle cerebral artery. Brain. 2005;128:2042-2051.
29. Leaf A, Kang J, Xiao Y, Billman G, Voskuyl R. The antiarrhythmic and anticonvulsant effects of dietary N-3 fatty acids. J Membr Biol. 1999;172:1-11.
30. Bourre JM. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J Nutr Health Aging. 2004;8:163-174.